That’s right. Shares of Novavax, Inc. (NASDAQ:NVAX), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), and Omeros Corporation (NASDAQ:OMER) suffered market beatdowns recently. Now they’re hanging on the clearance rack.
In fact, they’re cheap enough to make any sensible investor wonder if these deals are just too good to be true. To help you avoid falling into a value trap, here’s a look at what pushed them down -- and the catalysts that could lift them back up.
